Trial intelligence / Profile preview

Genetics of aspirin resistance

ISRCTN06023644Phase 4Completed

Sponsor
King's College London
Start
Jan 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Phase 4, open-label, single-arm trial of aspirin in cardiac morbidity, sponsored by King's College London. Primary endpoint: Presence of aspirin resistance. Started Jan 2007; status: completed.

02

Drugs

aspirin
03

Conditions

cardiac morbidity

Beyond the preview

Go deeper on ISRCTN06023644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN06023644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call